Cargando…

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction

Proprotein convertase subtilisin/kexin type 9 (PCSK9) interacts directly with cytoplasmic apoB and prevents its degradation via the autophagosome/lysosome pathway. This process affects VLDL and LDL production and influences atherogenesis. Here, we investigated the molecular machinery by which PCSK9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Hua, Krauss, Ronald M., Chang, Jeffrey T., Teng, Ba-Bie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Biochemistry and Molecular Biology 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794417/ https://www.ncbi.nlm.nih.gov/pubmed/29180444 http://dx.doi.org/10.1194/jlr.M078360

Ejemplares similares

The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
por: Keeter, William Coles, et al.
Publicado: (2022)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion
por: Chen, Xiao-Wei, et al.
Publicado: (2013)

A Critical Role of PCSK9 in Mediating IL-17-Producing T Cell Responses in Hyperlipidemia
por: Kim, Young Uk, et al.
Publicado: (2019)

Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels
por: Jiang, Chuantao, et al.
Publicado: (2018)

PCSK9 inhibitor inclisiran for treating atherosclerosis via regulation of endothelial cell pyroptosis
por: Kong, Ni, et al.
Publicado: (2022)

PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
por: Zulkapli, Rahayu, et al.
Publicado: (2023)

Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond
por: Seidah, Nabil G., et al.
Publicado: (2022)

Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4
por: Wang, Bingxiang, et al.
Publicado: (2021)

Apolipoprotein E Deficiency Causes Endothelial Dysfunction in the Mouse Retina
por: Zadeh, Jenia Kouchek, et al.
Publicado: (2019)

Comparison of Selenium Nanoparticles and Sodium Selenite on the Alleviation of Early Atherosclerosis by Inhibiting Endothelial Dysfunction and Inflammation in Apolipoprotein E-Deficient Mice
por: Xiao, Junying, et al.
Publicado: (2021)

New developments in atherosclerosis: clinical potential of PCSK9 inhibition
por: Giunzioni, Ilaria, et al.
Publicado: (2015)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
por: Punch, Emily, et al.
Publicado: (2022)

Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis
por: Wu, Yue, et al.
Publicado: (2019)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient mice
por: Cola, Maine S, et al.
Publicado: (2010)

High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice
por: Shiota, Asuka, et al.
Publicado: (2011)

Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
por: Holla, Øystein L, et al.
Publicado: (2007)

Long-term Expression of Apolipoprotein B mRNA-specific Hammerhead Ribozyme via scAAV8.2 Vector Inhibits Atherosclerosis in Mice
por: Nischal, Hersharan, et al.
Publicado: (2013)

PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
por: Luquero, Aureli, et al.
Publicado: (2021)

Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
por: Wang, Yanan, et al.
Publicado: (2023)

Adiponectin Receptor 2 Deficiency Results in Reduced Atherosclerosis in the Brachiocephalic Artery in Apolipoprotein E Deficient Mice
por: Lindgren, Anna, et al.
Publicado: (2013)

The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice
por: Ma, Juan, et al.
Publicado: (2022)

PCSK9 is not secreted from mature differentiated intestinal cells
por: Moreau, François, et al.
Publicado: (2021)

Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
por: Li, Jing, et al.
Publicado: (2011)

Atherosclerosis Vascular Endothelial Secretion Dysfunction and Smooth Muscle Cell Proliferation
por: Li, Junxi, et al.
Publicado: (2022)

MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4
por: Martino, Elisa, et al.
Publicado: (2023)

Physical activity to reduce PCSK9 levels
por: Tirandi, Amedeo, et al.
Publicado: (2022)

Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study
por: Coggi, Daniela, et al.
Publicado: (2021)

PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system
por: Lee, Jounghyun H., et al.
Publicado: (2023)

Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice
por: Xu, Yan-Yong, et al.
Publicado: (2015)

PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice
por: Wu, Yao, et al.
Publicado: (2015)

Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and aging
por: Meyrelles, Silvana S, et al.
Publicado: (2011)

TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
por: Watt, Victoria, et al.
Publicado: (2011)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
por: Fang, Bin, et al.
Publicado: (2018)

Retracted: Atherosclerosis Vascular Endothelial Secretion Dysfunction and Smooth Muscle Cell Proliferation
por: Healthcare Engineering, Journal of
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0g4e7harqo1j28o568k9copu21